AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dare Bioscience, Inc. Director's Dealing 2014

Oct 7, 2014

34825_dirs_2014-10-07_e52ecc2b-228a-4031-a7c1-a26d88caacb7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2014-10-03

Reporting Person: Kelley Susan L. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-10-03	Stock Option (Right to Buy)	$4.74	A	15000	Acquired	2024-10-02	Common Stock (15000)	Direct

Footnotes

F1: This option was granted on October 3, 2014. The shares underlying this option vest in three equal annual installments through October 3, 2017.